Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January -
February
-
March
-
April
-
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
- 2023 -
2024
-
2025
January 2023 - 19 products
Condromed 200 mg / 250 mg
90
PR
PR
k.A.
Capsules: 2 Active Agents
IBSA Institut
Biochimique SA
B
FB
G
L
IP
CI
Atoxyl Leman
250 g
3.40
6.30
10 %
Cream: 3 Active Agents
Leman SKL SA
D / SL / SG
FB
G
IP
CI
Etodolac NOBEL retard 600 mg
30
12.43
29.95
10 %
Coated tablets: Etodolacum 600 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
IP
CI
Etodolac NOBEL retard 600 mg
100
39.92
59.85
10 %
Coated tablets: Etodolacum 600 mg
NOBEL Pharma Schweiz AG
B / SL / SG
FB
G
L
IP
CI
Alitrecutan 10 mg
30
215.00
250.95
10 %
Soft capsules: Alitretinoinum 10 mg
Dermapharm AG
A / SL / SG
FB
G
L
IP
Alitrecutan 30 mg
30
215.00
250.95
10 %
Soft capsules: Alitretinoinum 30 mg
Dermapharm AG
A / SL / SG
FB
G
IP
CI
AciVision 30 mg/g
4.5 g
9.69
26.95
10 %
Ophtalmic ointment: Aciclovirum 30 mg
OmniVision AG
A / SL
FB
G
L
Zejula 100 mg
56
4030.15
4399.45
10 %
Coated tablets: Niraparibum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
L
Zejula 100 mg
84
6045.23
6510.20
10 %
Coated tablets: Niraparibum 100 mg
GlaxoSmithKline AG
A / SL
FB
G
IP
CM
Doxocur 500 mg
30
7.90
17.85
10 %
Capsules: Calcii Dobesilas Monohydricus 500 mg
OM Pharma Suisse SA
B / SL
FB
G
IP
CM
Doxocur 500 mg
60
13.91
31.55
10 %
Capsules: Calcii Dobesilas Monohydricus 500 mg
OM Pharma Suisse SA
B / SL
FB
G
IP
Cifoban 136 mmol/l
8
PR
PR
k.A.
Infusion solution: Trinatrii Citras Dihydricus
Fresenius Medical
Care (Schweiz) AG
B
FB
G
IP
Cifoban 136 mmol/l
8
PR
PR
k.A.
Infusion solution: Trinatrii Citras Dihydricus
Fresenius Medical
Care (Schweiz) AG
B
FB
G
IP
CI
Spaverin 40 mg
20
PR
PR
k.A.
Tablets: Drotaverini Hydrochloridum 40 mg
MEDITOP Switzerland AG
B
FB
G
IP
Spaverin 80 mg
10
PR
PR
k.A.
Tablets: Drotaverini Hydrochloridum 80 mg
MEDITOP Switzerland AG
B
FB
G
IP
Spaverin 80 mg
20
PR
PR
k.A.
Tablets: Drotaverini Hydrochloridum 80 mg
MEDITOP Switzerland AG
B
FB
G
Emge Biomed
20
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: Magnesium 300 mg
Biomed AG
D
FB
G
Emge Biomed
50
PR
PR
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: Magnesium 300 mg
Biomed AG
D
FB
G
IP
Brimonidine Labatec 2
mg/ml
5 ml
PR
PR
k.A.
collyre en solution: Brimonidini Tartras 2 mg/ml
Labatec Pharma SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
